7 Most Profitable Value Stocks to Buy Right Now
On April 2, Kevin Mahn, Hennion & Walsh Asset Management president and chief investment officer, joined 'Squawk Box' on CNBC to discuss market reactions to developments in the Iran war.
Glaxosmithkline Plc (GSK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,009,401 | $55,708,848 | 0.8% | |
| 2. | 270,147 | $14,909,438 | 1.65% | |
| 3. | 269,102 | $14,851,718 | 0.71% | |
| 4. | 161,978 | $8,939,566 | 2.52% | |
| 5. | 127,516 | $7,037,619 | 0.59% |
News See All
Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In an appearance on CNBC's Fast Money in January, Ray Stevens, CEO of Structure Therapeutics, discussed the unmet potential in the obesity market.
GSK (GSK) Announces 75.6% Vaccine Effectiveness for Arexvy in Real-World RSV Study
GSK (NYSE:GSK) is one of the best value stocks to buy now.
11 Best Value Stocks to Buy Now
On February 7, Richard Bernstein, the CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the current state of the equity markets and his firm's macro-driven investment strategy...
GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17%
GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now.
11 Undervalued European Stocks to Buy Now
European markets closed at a record high on February 11, with gains in commodity-related companies offsetting declines in technology and financials, while traders digested a solid US jobs report.
GSK plc (NYSE:GSK) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, a warm welcome to the GSK Full Year 2025 Results Call. I'm delighted to be joined today by Luke Miels, Nina Mojas, Deborah Waterhouse, Tony Wood and Julie Brown.
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) - Here's Why
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc (NYSE:GSK) on January 7 and set a price target of $55.60.
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and the pharma M&A outlook...
Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now?
GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now.
Hedge Fund Resource Center